NCT05715229
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05715229
Title Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy (G360-IIT)
Acronym G360-IIT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hackensack Meridian Health
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center, Georgetown University NOT_YET_RECRUITING Washington D.C. District of Columbia 20007 United States Details
John Theurer Cancer Center, Hackensack Meridian Health RECRUITING Hackensack New Jersey 07410 United States Details
Jersey Shore University Medical Center NOT_YET_RECRUITING Neptune City New Jersey 07753 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field